Navigation Links
Confirming gene silencing,,,mechanism by pGFP/GFP22 ,,,siRNA co-transfection

In addition to the specificity and efficiency of an siRNA sequence for a target gene, which are of high importance in post-transcriptional gene silencing (PTGS), the delivery of siRNA into cells is crucial. An efficient method to optimize transfection and gene silencing is critical for successful RNAi experiments. In this Application Note HeLaS3 cells were transfected with GFP expressing plasmid and Cy5-labeled siRNA against GFP, both individually and in combination, using QIAGEN transfection reagents. Uptake of labeled siRNA and the gene silencing effect were monitored for up to 24 hours after transfection. Efficient gene silencing was achieved which confirms the operation of RNAi mechanism in the selected cell line.
The technique of RNAi has the potential to revolutionize functional genomics. The pathways and mechanisms of RNAi are currently under intense investigation, and a good understanding of these is essential to allow scientists to exploit the applications of RNAi. Simple and efficient methods for monitoring gene silencing are important tools for RNAi experiments. In this Application Note we describe the evaluation of a method using fluorescent labels to determine transfection efficiency and the gene silencing effect.
HeLaS3 cells were transfected with siRNA using RNAiFect Reagent. TransMessenger Reagent was used for the transfection of GFP expressing plasmid (pGFP). Cells were also co-transfected with both plasmid DNA and siRNA using TransMessenger Reagent. The uptake of siRNA into mammalian cells was monitored using fluorescent labeled siRNA and the gene silencing effect and level of cellular protein expression were quantified at 4, 8, and 24 hours after transfection.
Materials and methods
HeLa S3 cells( ATCC, CCL-2.2) were plated at 5 x 104 cells /well in 24-well plates and incubated for 24 hours before transfection. Cells were transfected with 0.9 g of GFP22-siRNA (QIAGEN, Cat. # 1022064) per well using RNAiFect Reagent (QIAGEN, Cat. #301605). GFP22-siRNA has a homologous sequence to GFP mRNA. It was transfected unlabeled or labeled with Cy5. For GFP expression, cells were transfected with 0.2 g of pGFP in each well using Trans- Messenger Reagent (QIAGEN, Cat. # 301525). For co-transfection of GFP22-siRNA and pGFP, Trans- Messenger Reagent was also used. The recommended protocols, described in the QIAGEN RNAi- Fect handbook and the supplementary protocol for co-transfection of adherent cells with siRNA and plasmid DNA using TansMessenger Reagent was followed, using the optimized ratio of RNAi- Fect Reagent : siRNA and Trans- Messenger Reagent : siRNA of 1:5 as determined previously.
Analysis of GFP expression and Cy5 fluorescence was performed using the Agilent 2100 bioanalyzer with pressure cartridge for flow cytometric studies. For the analysis with the Agilent 2100 bioanalyzer, cells were trypsinized and washed twice in phosphate buffered saline (PBS), and then resuspended in Cell Buffer (CB) at a dilution of 1 x 106 -1.5 x 106 per milliliter. Cells were stained for 30 minutes at RT with the live dyes calcein-AM (Molecular Probes, Cat. # C-3099) or carboxynaphthofluorescein diacetate( CBNF) (Molecular Probes, Cat. # C-13196). Dye concentrations of 2.5 M were used for staining. Ten microliters of each sample were loaded on a microfluidic chip for analysis. Microfluidic chips and CB buffer were supplied with the Agilent Cell Fluorescence LabChip kit. Cy5 fluorescence indicated the efficiency of siRNA uptake and calcein-AM staining monitored the cell viability. In cells transfected with pGFP, GFP fluorescence indicated the transfection efficiency and the proportion of living cells was monitored by CBNF staining. The efficiency of gene silencing in cells co-transfected with Cy5-siRNA and pGFP was monitored by GFP fluorescence, and the viability of the cells was monitored by CBNF staining. Fluorescence microscopy was used to compare the 2100 bioanalyzer results 24 hours after transfection.
Results and discussion

Cells were analyzed 4, 8, and 24 hours after transfection using the 2100 bioanalyzer. As controls, untransfected cells were used, either unstained, stained with calcein- AM or CBNF alone. Controls were analyzed in parallel with the transfected cells (data not shown). In cells transfected with Cy5- labeled siRNA, Cy5 positive cells were detectable after 4 hours (figure 1). Transfection efficiency measurements after calcein staining showed that over 80 % of the live cells were Cy5-positive. This picture remained constant after 24 hours. In cells transfected with pGFP, the proportions of live cells expressing GFP increased from 22.4 % after 4 hours to 57.6 % after 24 hours. Co-transfection of pGFP and siRNA resulted in efficient gene silencing and results after each time point were compared and plotted (figure 2). A strong gene silencing effect was measured and by 24 hours the measured down-regulation of GFP expression was up to 77 %.

In a separate experiment, cells were transfected with pGFP alone, pGFP with unlabeled siRNA, and pGFP with Cy5-labeled siRNA to determine whether the Cy5 label affected gene silencing. Results, 24 hours after transfection, showed similar down regulation of the GFP expression, meaning that the Cy5 label did not interfere significantly with the gene silencing effect (figure 3).

Cells were also examined by fluorescence microscopy confirming the results from the 2100 bioanalyzer for GFP existence in cells (figure 4).

Conclusions
Uptake of labeled siRNA and its gene silencing effect were quantitatively monitored using the flow cytometry capability of the Agilent 2100 bioanalyzer. Successful co-transfection of pGFP and Cy5-labeled siRNA using Trans- Messenger reagent was achieved. GFP expression of up to 56.9 %, and silencing of GFP expression to levels below 10 % confirmed the efficient transfection and silencing mechanism in the selected cell line.
The measurement of protein expression in viable cells with the Agilent 2100 bioanalyzer is fast, accurate and automated, providing efficient methods to monitor and optimize any gene silencing experiment. QIAGEN reagents and chemically synthesized siRNA probes are highly efficient and reliable.



'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Confirming RNAi Effects Is Now Easier Than Ever

Post Your Comments:
(Date:11/24/2009)...Health care employment grew by 29,000 jobs in Oct...onsistent growth during the U.S. recession. Howeve...le, and health systems are coming closer to having...t administrators. , (Vocu...tinued growing in October despite the shedding of ...
(Date:11/24/2009)...Calif., Nov. 24 Neuroges...any focused on developing and commercializing nove...Anthony DiTonno, President and Chief Executive Off...iper Jaffray Health Care Conference, to be held De...ew York, New York. ,, Mr. DiTonno and Stephen ...
(Date:11/24/2009)...he FBI recently approved the Promega PowerPlex 16 ... or generating DNA records for the National DNA In... USA (PRWEB) -- The FBI recently approved the Prom...atories participating in, or generating DNA record...currently contains more than seven million profile...
(Date:11/24/2009)...vember 24 Shire plc (LSE...harmaceutical company, today,announced that it has...for,velaglucerase alfa, the company,s enzyme repla... Type 1 Gaucher disease. This is the third marketi...n submitted, with previous,submissions in the Unit...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
...IEGO, Oct. 6 Biocept, Inc. ("Biocept"), an,emergi...pointment of,Stephen M. Coutts, Ph.D. as CEO, Pres.... Dennis, Ph.D., as Director. Biocept also announc...d Director, Gordon F. Janko., "We are pleased to ...,in our field, and believe he is a good fit with o...
...IDGE, Mass. and TOKYO, Oct. 6 Galenea Corp. and,O... extension and expansion,of their research and dev...n working together since January 2005 to discover ...other central nervous system (CNS),diseases. The n... initial,five-year alliance and brings the total c...
...w Rochelle, NY, October 3, 2008Novel platform tech...driving the development of molecular diagnostics, ...s (GEN). The payoff for successful molecular diag...ormation predicts that this market currently excee...ion in four years, according to an article in the ...
Other Biology Technology:Biocept, Inc. Announces CEO and Director Appointments 2Galenea and Otsuka Pharmaceutical Extend & Expand Schizophrenia Research Collaboration 2Galenea and Otsuka Pharmaceutical Extend & Expand Schizophrenia Research Collaboration 3Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics 2
(Date:11/24/2009)...an College of Medical Toxicology (ACMT) have signe...f the Journal of Medical Toxicology (JMT), the o...10. It was previously published by the University...al Toxicology , an international, peer-reviewed jo...ractice of medical toxicology. The quarterly jour...
(Date:11/24/2009)...ble in Spanish . , The presence of increase...atory substances in the blood, hinders the loss an...ch project of the University of Navarra conducted ...hool of Pharmacy. , The project, entitled "A nut...e control of body weight and inflammation," examin...
(Date:11/23/2009)...ldlife Conservation Society says that western lowl...ic of Congopart of the "mother lode" of more than ...increasingly threatened by growing humans activity...n of the swamp forests adjacent to the southwest b...veys confirmed that high densities of the great ap...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Scientists Learn How Cancer Drugs Cause Hypertension 53768 1Scientists Learn How Cancer Drugs Cause Hypertension 53768 2George Barrett Named Chairman and CEO of Cardinal Health 53763 1George Barrett Named Chairman and CEO of Cardinal Health 53763 2George Barrett Named Chairman and CEO of Cardinal Health 53763 3George Barrett Named Chairman and CEO of Cardinal Health 53763 4Portable Health Care Records Now Available for Consumers 53759 1Portable Health Care Records Now Available for Consumers 53759 2
...w generation of pharmaceuticals are studying cellu...ind to upstream sequences of genes to turn the exp...cal companies are also hoping to develop drugs tha...actors as a way to short-circuit the harmful effec...of California, San Diego on June 16 reported new f...
...a daunting task to find a smoking gun for Darwinia... not just when and how a specific gene mutated but...real-world dominance of one population over anothe...s experiment that forced bacteria to compete in a ...oday offer the first glimpse of how individual gen...
...at it allows scientists peering inside cells to di...al protein they are studying has been developed an...oward Hughes Medical Institute,s Janelia Farm Rese...he National Institutes of Health and Florida State...e resolution of conventional optical microscopes, ...
Other Biology News:Cells use mix-and-match approach to tailor regulation of genes 2Ready, set, mutate?and may the best microbe win 2Ready, set, mutate?and may the best microbe win 3New light microscope sharpens scientists' focus 2New light microscope sharpens scientists' focus 3New light microscope sharpens scientists' focus 4New light microscope sharpens scientists' focus 5New light microscope sharpens scientists' focus 6
mitochondrial proteins (human heart) for SDS-polyacrylamide gel electrophoresis from Molecular Probes (Invitrogen)
Sentrix Custom-96 Expression Array Matrix (1) from Illumina
Primate IFN-gamma ELISpot Development Kit from R&D Systems
Rabbit Anti-Rat Heme Oxygenase-1 (2-23) Polyclonal Antibody, Unconjugated from Calbiochem
Biology Products: